Telomere dysfunction alters the chemotherapeutic profile of transformed cells

Kee Ho Lee, K. Lenhard Rudolph, Yeun Jin Ju, Roger A. Greenberg, Linda Cannizzaro, Lynda Chin, Sarah R. Weiler, Ronald A. DePinho

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Telomerase inhibition has been touted as a novel cancer-selective therapeutic goal based on the observation of high telomerase levels in most cancers and the importance of telomere maintenance in long-term cellular growth and survival. Here, the impact of telomere dysfunction on chemotherapeutic responses was assessed in normal and neoplastic cells derived from telomerase RNA null (mTERC-/-) mice. Telomere dysfunction, rather than telomerase per se, was found to be the principal determinant governing chemosensitivity specifically to agents that induced doublestranded DNA breaks (DSB). Enhanced chemosensitivity in telomere dysfunctional cells was linked to therapy-induced fragmentation and multichromosomal fusions, whereas telomerase reconstitution restored genomic integrity and chemoresistance. Loss of p53 function muted the cytotoxic effects of DSB-inducing agents in cells with telomere dysfunction. Together, these results point to the combined use of DSB-inducing agents and telomere maintenance inhibition as an effective anticancer therapeutic approach particularly in cells with intact p53-dependent checkpoint responses.

Original languageEnglish (US)
Pages (from-to)3381-3386
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number6
DOIs
StatePublished - Mar 13 2001

Fingerprint

Telomere
Telomerase
DNA Breaks
Maintenance
Neoplasms
Therapeutics
Observation
Growth

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Lee, K. H., Rudolph, K. L., Ju, Y. J., Greenberg, R. A., Cannizzaro, L., Chin, L., ... DePinho, R. A. (2001). Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proceedings of the National Academy of Sciences of the United States of America, 98(6), 3381-3386. https://doi.org/10.1073/pnas.051629198

Telomere dysfunction alters the chemotherapeutic profile of transformed cells. / Lee, Kee Ho; Rudolph, K. Lenhard; Ju, Yeun Jin; Greenberg, Roger A.; Cannizzaro, Linda; Chin, Lynda; Weiler, Sarah R.; DePinho, Ronald A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 6, 13.03.2001, p. 3381-3386.

Research output: Contribution to journalArticle

Lee, KH, Rudolph, KL, Ju, YJ, Greenberg, RA, Cannizzaro, L, Chin, L, Weiler, SR & DePinho, RA 2001, 'Telomere dysfunction alters the chemotherapeutic profile of transformed cells', Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3381-3386. https://doi.org/10.1073/pnas.051629198
Lee, Kee Ho ; Rudolph, K. Lenhard ; Ju, Yeun Jin ; Greenberg, Roger A. ; Cannizzaro, Linda ; Chin, Lynda ; Weiler, Sarah R. ; DePinho, Ronald A. / Telomere dysfunction alters the chemotherapeutic profile of transformed cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Vol. 98, No. 6. pp. 3381-3386.
@article{10d0d1ac84e84a979465cfcff6d54833,
title = "Telomere dysfunction alters the chemotherapeutic profile of transformed cells",
abstract = "Telomerase inhibition has been touted as a novel cancer-selective therapeutic goal based on the observation of high telomerase levels in most cancers and the importance of telomere maintenance in long-term cellular growth and survival. Here, the impact of telomere dysfunction on chemotherapeutic responses was assessed in normal and neoplastic cells derived from telomerase RNA null (mTERC-/-) mice. Telomere dysfunction, rather than telomerase per se, was found to be the principal determinant governing chemosensitivity specifically to agents that induced doublestranded DNA breaks (DSB). Enhanced chemosensitivity in telomere dysfunctional cells was linked to therapy-induced fragmentation and multichromosomal fusions, whereas telomerase reconstitution restored genomic integrity and chemoresistance. Loss of p53 function muted the cytotoxic effects of DSB-inducing agents in cells with telomere dysfunction. Together, these results point to the combined use of DSB-inducing agents and telomere maintenance inhibition as an effective anticancer therapeutic approach particularly in cells with intact p53-dependent checkpoint responses.",
author = "Lee, {Kee Ho} and Rudolph, {K. Lenhard} and Ju, {Yeun Jin} and Greenberg, {Roger A.} and Linda Cannizzaro and Lynda Chin and Weiler, {Sarah R.} and DePinho, {Ronald A.}",
year = "2001",
month = "3",
day = "13",
doi = "10.1073/pnas.051629198",
language = "English (US)",
volume = "98",
pages = "3381--3386",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Telomere dysfunction alters the chemotherapeutic profile of transformed cells

AU - Lee, Kee Ho

AU - Rudolph, K. Lenhard

AU - Ju, Yeun Jin

AU - Greenberg, Roger A.

AU - Cannizzaro, Linda

AU - Chin, Lynda

AU - Weiler, Sarah R.

AU - DePinho, Ronald A.

PY - 2001/3/13

Y1 - 2001/3/13

N2 - Telomerase inhibition has been touted as a novel cancer-selective therapeutic goal based on the observation of high telomerase levels in most cancers and the importance of telomere maintenance in long-term cellular growth and survival. Here, the impact of telomere dysfunction on chemotherapeutic responses was assessed in normal and neoplastic cells derived from telomerase RNA null (mTERC-/-) mice. Telomere dysfunction, rather than telomerase per se, was found to be the principal determinant governing chemosensitivity specifically to agents that induced doublestranded DNA breaks (DSB). Enhanced chemosensitivity in telomere dysfunctional cells was linked to therapy-induced fragmentation and multichromosomal fusions, whereas telomerase reconstitution restored genomic integrity and chemoresistance. Loss of p53 function muted the cytotoxic effects of DSB-inducing agents in cells with telomere dysfunction. Together, these results point to the combined use of DSB-inducing agents and telomere maintenance inhibition as an effective anticancer therapeutic approach particularly in cells with intact p53-dependent checkpoint responses.

AB - Telomerase inhibition has been touted as a novel cancer-selective therapeutic goal based on the observation of high telomerase levels in most cancers and the importance of telomere maintenance in long-term cellular growth and survival. Here, the impact of telomere dysfunction on chemotherapeutic responses was assessed in normal and neoplastic cells derived from telomerase RNA null (mTERC-/-) mice. Telomere dysfunction, rather than telomerase per se, was found to be the principal determinant governing chemosensitivity specifically to agents that induced doublestranded DNA breaks (DSB). Enhanced chemosensitivity in telomere dysfunctional cells was linked to therapy-induced fragmentation and multichromosomal fusions, whereas telomerase reconstitution restored genomic integrity and chemoresistance. Loss of p53 function muted the cytotoxic effects of DSB-inducing agents in cells with telomere dysfunction. Together, these results point to the combined use of DSB-inducing agents and telomere maintenance inhibition as an effective anticancer therapeutic approach particularly in cells with intact p53-dependent checkpoint responses.

UR - http://www.scopus.com/inward/record.url?scp=0035853058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035853058&partnerID=8YFLogxK

U2 - 10.1073/pnas.051629198

DO - 10.1073/pnas.051629198

M3 - Article

C2 - 11248087

AN - SCOPUS:0035853058

VL - 98

SP - 3381

EP - 3386

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -